Developer docs
API playgroundTry for free, no card

Search company profiles

Creative Proteomics

Full company profile

uuid0009vxb

Namestring
Creative Proteomics
Legal namestring
Creative Proteomics
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Creative Proteomics is a privately held contract research organization (CRO) headquartered in Shirley, USA, with a European contact office in Germany and approximately 51–100 employees. The company delivers mass spectrometry-based analytical services across proteomics, metabolomics, lipidomics, glycomics, peptidomics, and bioinformatics, using platforms including LC-MS/MS, GC-MS, ion mobility spectrometry, NMR spectroscopy, and SPR/Biacore. It serves pharmaceutical and biotechnology organizations, academic research institutions, and plant science researchers, providing fee-for-service laboratory analysis via a custom quote-based pricing model and direct online inquiry/ordering.

The company's core product portfolio is organized around six service pillars (Proteomics, Metabolomics, Lipidomics, Glycomics, Bioinformatics) augmented by specialized offerings including spatial omics, multi-omics integration, single-cell metabolomics and transcriptomics, flow cytometry, amino acid analysis, host cell protein analysis, and custom peptide/protein synthesis. MassTarget™ functions as a drug-discovery-focused sub-brand bundling MS-based binding assays (AS-MS, BLI, native ESI-MS), chemoproteomics (ABPP-MS), thermal proteomics (TPP, TSA), high-throughput MS screening, ADME/DMPK/PK-PD, and AI-driven multi-omics integration for pharmaceutical R&D customers. AI/ML capabilities are integrated into bioinformatics pipelines through third-party tools such as SIRIUS/CSI:FingerID, GNPS molecular networking, and deep learning peak detection models.

The business operates a sales-led, B2B laboratory services go-to-market model with digital-first customer acquisition through an SEO-optimized website, content marketing, social media, and 24/7 customer service. Customers submit project descriptions and receive customized project plans and quotes. The company distributes globally through direct website ordering, email/phone inquiries, and a distributor network. Notable disclosed customers include AbbVie, University of Cambridge, Oxford, Yale, Stanford, Berkeley, Toronto, Georgia Tech, Louisville, and Brigham and Women's Hospital. No funding, M&A, or revenue disclosures are available, and the company has no parent organization or public listing.

Short descriptiontext

Creative Proteomics is a US-based CRO providing mass spectrometry-based proteomics, metabolomics, lipidomics, glycomics, and bioinformatics services to pharmaceutical companies, academic institutions, and plant science researchers via a custom quote-based, fee-for-service model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersShirley, United States
HQ citystring
Shirley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
proteomics services, metabolomics analysis, mass spectrometry, lipidomics profiling, bioinformatics analysis
Industry4 codes
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
Product category
Analytical Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Testing Services
TypeProfessional Services
Description

Fee-for-service laboratory analysis for proteomics, metabolomics, glycomics, lipidomics, and bioinformatics. Customers submit samples and receive analytical results with data interpretation. Pricing is quote-based based on sample complexity and analysis requirements.

creative-proteomics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom Project-Based Pricing
ModelOtherBilling cadencePay-as-you-go
Notes

No standardized pricing tiers are publicly listed. Customers are required to submit an inquiry or project description to receive a customized quote. The company provides sample submission guidelines and detailed service descriptions to help customers understand the scope before requesting pricing.

creative-proteomics.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Creative Proteomics is a contract research organization that delivers mass spectrometry- and NMR-based analytical services spanning proteomics, metabolomics, lipidomics, glycomics, peptidomics, spatial omics, and bioinformatics. Customers submit biological samples and receive quantitative analytical results with data interpretation, supported by specialized drug discovery offerings via its MassTarget™ platform. The company serves pharmaceutical, biotechnology, and academic research customers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Detection of 200+ metabolites per single cell using advanced IMS-resolved nanoESI-MS techniques
+1 more record
Product overview1 text field

Creative Proteomics operates as a multi-service omics provider offering a portfolio of interrelated analytical services centered on mass spectrometry and NMR-based platforms. The core offering consists of six main service pillars: Proteomics Service, Metabolomics Service, Lipidomics Service, Glycomics Service, and Bioinformatics Service, each available as standalone offerings. These core services are augmented by specialized sub-services (Peptidomics, Spatial Omics, Multi-omics Integrative Services) and adjacent offerings (Flow Cytometry, Amino Acid Analysis, Host Cell Protein Analysis). The MassTarget™ sub-brand functions as a drug-discovery-specific platform within the broader portfolio, bundling MS-based binding assays, chemoproteomics, thermal proteomics, high-throughput screening, ADME/DMPK, and AI-driven multi-omics integration specifically for pharmaceutical R&D. Technology foundations span LC-MS/MS, GC-MS, NMR spectroscopy, ion mobility MS, and SPR/Biacore, applied across human/animal, plant, and microbial sample types.

Product and service17 records
1Proteomics Service
CategoryCore Analytical Service
Description

Comprehensive proteomics service encompassing protein identification, quantification, post-translational modification analysis, protein-protein interaction studies, top-down and peptidomics approaches, de novo sequencing, and subcellular proteomics using LC-MS/MS platforms. Targeted at pharmaceutical, biotech, and academic researchers.

2Metabolomics Service
CategoryCore Analytical Service
Description

Full-spectrum metabolomics services spanning untargeted and targeted metabolomics, metabolic flux analysis, unknown metabolite identification, xenobiotic metabolite analysis, and plant metabolomics using LC-MS/MS and GC-MS platforms. For pharma, biotech, academic, plant science, and microbiome researchers.

3Lipidomics Service
CategoryCore Analytical Service
Description

Qualitative and quantitative analysis of lipids and their metabolic pathways, including untargeted and targeted lipidomics for plants, yeast, and mammals, covering fatty acids, sphingolipids, glycerolipids, phospholipids, ceramides, sterols, and eicosanoids.

4Glycomics Service
CategoryCore Analytical Service
Description

Glycomics services including N-glycan and O-glycan profiling, glycan quantification and sequencing, structural characterization of glycans, glycopeptide analysis, glycan-related microarray assays, polysaccharide analysis, and starch analysis.

5Bioinformatics Service
CategoryCore Analytical Service
Description

Bioinformatics support for proteomics and metabolomics studies including functional annotation, enrichment analysis, clustering analysis, statistical analysis, network analysis, and multivariate analysis to interpret high-throughput omics data.

6Spatial Omics Services
CategorySpecialty Analytical Service
Description

Spatial omics services encompassing digital and molecular pathology, spatial metabolomics via MALDI-MSI, DESI-MSI, and LA-ICP-MS imaging, spatial transcriptomics, spatial proteomics, and integrated spatial multi-omics profiling.

7Multi-omics Integrative Services
CategorySpecialty Analytical Service
Description

Integrated multi-omics analysis combining transcriptomics, proteomics, metabolomics, lipidomics, metagenomics, and epigenomics data to provide comprehensive biological insights for drug discovery and disease research.

8Peptidomics Service
CategorySpecialty Analytical Service
Description

Peptidomics service for identification and quantitative analysis of endogenous peptides in biological samples, including characterization of peptide biomarkers, untargeted peptidomics, and immunopeptidomics using LC-MS/MS.

9Customized Synthesized Peptide and Proteins
CategorySynthesis Service
Description

Custom peptide and protein synthesis services using various synthetic methods with quality assurance documentation for pharmaceutical and biotechnology research applications.

10MassTarget™ Drug Discovery Platform
CategoryDrug Discovery Platform
Description

Drug discovery platform offering label-free binding and affinity services (AS-MS, BLI, CE-MS, native ESI-MS, ion mobility MS), protein footprinting (FPOP, HDX-MS, LiP-MS), thermal shift proteomics (TPP, TSA, PISA), chemoproteomics (ABPP-MS), high-throughput MS screening, enzyme activity assays, cell-based MS drug screening, ADME/DMPK/PK-PD research, and multi-omics integration.

11Flow Cytometry Service
CategorySpecialty Analytical Service
Description

Flow cytometry and FACS sorting services for single-cell analysis applications in research and diagnostics.

12Amino Acid Analysis (AAA)
CategorySpecialty Analytical Service
Description

Analytical service for amino acid quantification and characterization in biological samples.

13Host Cell Protein Analysis
CategorySpecialty Analytical Service
Description

Identification and quantification of residual host cell proteins in biopharmaceutical manufacturing processes for quality control.

14De Novo Peptide and Protein Sequencing
CategorySpecialty Analytical Service
Description

Peptide and protein de novo sequencing service for identifying novel peptides, unsequenced organisms, and antibody drugs that cannot be detected by database search methods.

15SPR Assay Service (Biacore)
CategorySpecialty Analytical Service
Description

Surface Plasmon Resonance (SPR) assay service using Biacore instruments for label-free, real-time measurement of biomolecular interactions including binding kinetics and affinity determination.

16Single Cell Metabolomics
CategorySpecialty Analytical Service
Description

Single-cell metabolomics services profiling the metabolome of individual cells using nanoESI-MS and ion mobility spectrometry to reveal metabolic heterogeneity at cellular resolution.

17Single Cell Transcriptomics
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialized metabolomics CRO offering untargeted and targeted metabolite profiling services using mass spectrometry. Directly comparable to Creative Proteomics's metabolomics service line and competes for the same pharma and academic sponsors.

TypeDirect peer
Description

Proteomics-focused CRO providing discovery proteomics, targeted proteomics (using its Spectronaut software), and protein biomarker services. Most direct head-to-head competitor for Creative Proteomics's proteomics service line.

TypeBroad incumbent
Description

Global testing CRO with a sizeable biopharma services division covering proteomics, metabolomics, and genomics. Overlaps broadly with Creative Proteomics but operates at vastly larger scale and with broader geographic reach.

TypeBroad incumbent
Description

Large CRO offering discovery, safety assessment, and laboratory services including protein characterization and bioanalytical support. A scaled incumbent competing for the same biopharma outsourcing dollars.

TypeBroad incumbent
Description

Owns both the dominant mass-spectrometry instrument line (Orbitrap, Q Exactive) used by Creative Proteomics and the PPD CRO business. A vertically integrated incumbent that competes as both vendor and analytical-services provider.

TypeBroad incumbent
Description

Global CRO/CDMO offering discovery, preclinical, and laboratory services to biopharma. Competes on multi-omics and bioanalytical work and operates at much larger scale with broader geographic coverage.

TypeEmerging player
Description

Proteomics platform company offering targeted protein biomarker analysis via Proximity Extension Assay. Adjacent rather than direct, since Olink sells a kit-and-platform model, but it overlaps with Creative Proteomics's targeted proteomics workflows.

TypeDirect peer
Description

Multi-omics services provider offering genomics, proteomics, and metabolomics on a fee-for-service basis. Directly comparable service model, customer mix, and global intake footprint.

TypeBroad incumbent
Description

Drug-discovery CRO offering proteomics, metabolomics, and integrated multi-omics as part of broader discovery collaborations. Overlaps with Creative Proteomics's MassTarget drug-discovery workflow.

TypeBroad incumbent
Description

Life-science services company offering gene synthesis, protein production, peptide synthesis, and analytical services. Comparable on the custom peptide/protein synthesis and protein characterization lines, broader in scope elsewhere.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Creative Proteomics

Analytical Laboratory Servicescreative-proteomics.com

Creative Proteomics is a US-based CRO providing mass spectrometry-based proteomics, metabolomics, lipidomics, glycomics, and bioinformatics services to pharmaceutical companies, academic institutions, and plant science researchers via a custom quote-based, fee-for-service model.

What Creative Proteomics does

Creative Proteomics is a privately held contract research organization (CRO) headquartered in Shirley, USA, with a European contact office in Germany and approximately 51–100 employees. The company delivers mass spectrometry-based analytical services across proteomics, metabolomics, lipidomics, glycomics, peptidomics, and bioinformatics, using platforms including LC-MS/MS, GC-MS, ion mobility spectrometry, NMR spectroscopy, and SPR/Biacore. It serves pharmaceutical and biotechnology organizations, academic research institutions, and plant science researchers, providing fee-for-service laboratory analysis via a custom quote-based pricing model and direct online inquiry/ordering.

The company's core product portfolio is organized around six service pillars (Proteomics, Metabolomics, Lipidomics, Glycomics, Bioinformatics) augmented by specialized offerings including spatial omics, multi-omics integration, single-cell metabolomics and transcriptomics, flow cytometry, amino acid analysis, host cell protein analysis, and custom peptide/protein synthesis. MassTarget™ functions as a drug-discovery-focused sub-brand bundling MS-based binding assays (AS-MS, BLI, native ESI-MS), chemoproteomics (ABPP-MS), thermal proteomics (TPP, TSA), high-throughput MS screening, ADME/DMPK/PK-PD, and AI-driven multi-omics integration for pharmaceutical R&D customers. AI/ML capabilities are integrated into bioinformatics pipelines through third-party tools such as SIRIUS/CSI:FingerID, GNPS molecular networking, and deep learning peak detection models.

The business operates a sales-led, B2B laboratory services go-to-market model with digital-first customer acquisition through an SEO-optimized website, content marketing, social media, and 24/7 customer service. Customers submit project descriptions and receive customized project plans and quotes. The company distributes globally through direct website ordering, email/phone inquiries, and a distributor network. Notable disclosed customers include AbbVie, University of Cambridge, Oxford, Yale, Stanford, Berkeley, Toronto, Georgia Tech, Louisville, and Brigham and Women's Hospital. No funding, M&A, or revenue disclosures are available, and the company has no parent organization or public listing.

Creative Proteomics firmographics

Firmographics
Name
Creative Proteomics
Legal name
Creative Proteomics
Website
https://creative-proteomics.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Creative Proteomics is a US-based CRO providing mass spectrometry-based proteomics, metabolomics, lipidomics, glycomics, and bioinformatics services to pharmaceutical companies, academic institutions, and plant science researchers via a custom quote-based, fee-for-service model.
Ownership category
akta.pro rank

Creative Proteomics industry classification

Industry
Product category
Analytical Laboratory Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
akta.pro industry
PRIMARYHLAGANAB
Proteomics & Mass Spectrometry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAG
Proteomics & Biomarker Analytical Testing
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Proteomics services
  • Metabolomics analysis
  • Mass spectrometry
  • Lipidomics profiling
  • Bioinformatics analysis

Where Creative Proteomics is headquartered

Location

Headquarters

HQ city
Shirley
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Creative Proteomics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Laboratory Testing Services: Fee-for-service laboratory analysis for proteomics, metabolomics, glycomics, lipidomics, and bioinformatics. Customers submit samples and receive analytical results with data interpretation. Pricing is quote-based based on sample complexity and analysis requirements.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCustom Project-Based Pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Creative Proteomics product offering

Product offering

Core offering

Creative Proteomics is a contract research organization that delivers mass spectrometry- and NMR-based analytical services spanning proteomics, metabolomics, lipidomics, glycomics, peptidomics, spatial omics, and bioinformatics. Customers submit biological samples and receive quantitative analytical results with data interpretation, supported by specialized drug discovery offerings via its MassTarget™ platform. The company serves pharmaceutical, biotechnology, and academic research customers globally.

Product overview

Creative Proteomics operates as a multi-service omics provider offering a portfolio of interrelated analytical services centered on mass spectrometry and NMR-based platforms. The core offering consists of six main service pillars: Proteomics Service, Metabolomics Service, Lipidomics Service, Glycomics Service, and Bioinformatics Service, each available as standalone offerings. These core services are augmented by specialized sub-services (Peptidomics, Spatial Omics, Multi-omics Integrative Services) and adjacent offerings (Flow Cytometry, Amino Acid Analysis, Host Cell Protein Analysis). The MassTarget™ sub-brand functions as a drug-discovery-specific platform within the broader portfolio, bundling MS-based binding assays, chemoproteomics, thermal proteomics, high-throughput screening, ADME/DMPK, and AI-driven multi-omics integration specifically for pharmaceutical R&D. Technology foundations span LC-MS/MS, GC-MS, NMR spectroscopy, ion mobility MS, and SPR/Biacore, applied across human/animal, plant, and microbial sample types.

Differentiator

Problem solved

Functional benefit

Products and services

  • Proteomics Service Comprehensive proteomics service encompassing protein identification, quantification, post-translational modification analysis, protein-protein interaction studies, top-down and peptidomics approaches, de novo sequencing, and subcellular proteomics using LC-MS/MS platforms. Targeted at pharmaceutical, biotech, and academic researchers.
  • Metabolomics Service Full-spectrum metabolomics services spanning untargeted and targeted metabolomics, metabolic flux analysis, unknown metabolite identification, xenobiotic metabolite analysis, and plant metabolomics using LC-MS/MS and GC-MS platforms. For pharma, biotech, academic, plant science, and microbiome researchers.
  • Lipidomics Service Qualitative and quantitative analysis of lipids and their metabolic pathways, including untargeted and targeted lipidomics for plants, yeast, and mammals, covering fatty acids, sphingolipids, glycerolipids, phospholipids, ceramides, sterols, and eicosanoids.
  • Glycomics Service Glycomics services including N-glycan and O-glycan profiling, glycan quantification and sequencing, structural characterization of glycans, glycopeptide analysis, glycan-related microarray assays, polysaccharide analysis, and starch analysis.
  • Bioinformatics Service Bioinformatics support for proteomics and metabolomics studies including functional annotation, enrichment analysis, clustering analysis, statistical analysis, network analysis, and multivariate analysis to interpret high-throughput omics data.
  • Spatial Omics Services Spatial omics services encompassing digital and molecular pathology, spatial metabolomics via MALDI-MSI, DESI-MSI, and LA-ICP-MS imaging, spatial transcriptomics, spatial proteomics, and integrated spatial multi-omics profiling.
  • Multi-omics Integrative Services Integrated multi-omics analysis combining transcriptomics, proteomics, metabolomics, lipidomics, metagenomics, and epigenomics data to provide comprehensive biological insights for drug discovery and disease research.
  • Peptidomics Service Peptidomics service for identification and quantitative analysis of endogenous peptides in biological samples, including characterization of peptide biomarkers, untargeted peptidomics, and immunopeptidomics using LC-MS/MS.
  • Customized Synthesized Peptide and Proteins Custom peptide and protein synthesis services using various synthetic methods with quality assurance documentation for pharmaceutical and biotechnology research applications.
  • MassTarget™ Drug Discovery Platform Drug discovery platform offering label-free binding and affinity services (AS-MS, BLI, CE-MS, native ESI-MS, ion mobility MS), protein footprinting (FPOP, HDX-MS, LiP-MS), thermal shift proteomics (TPP, TSA, PISA), chemoproteomics (ABPP-MS), high-throughput MS screening, enzyme activity assays, cell-based MS drug screening, ADME/DMPK/PK-PD research, and multi-omics integration.
  • Flow Cytometry Service Flow cytometry and FACS sorting services for single-cell analysis applications in research and diagnostics.
  • Amino Acid Analysis (AAA) Analytical service for amino acid quantification and characterization in biological samples.
  • Host Cell Protein Analysis Identification and quantification of residual host cell proteins in biopharmaceutical manufacturing processes for quality control.
  • De Novo Peptide and Protein Sequencing Peptide and protein de novo sequencing service for identifying novel peptides, unsequenced organisms, and antibody drugs that cannot be detected by database search methods.
  • SPR Assay Service (Biacore) Surface Plasmon Resonance (SPR) assay service using Biacore instruments for label-free, real-time measurement of biomolecular interactions including binding kinetics and affinity determination.
  • Single Cell Metabolomics Single-cell metabolomics services profiling the metabolome of individual cells using nanoESI-MS and ion mobility spectrometry to reveal metabolic heterogeneity at cellular resolution.
  • Single Cell Transcriptomics

Quantifiable outcome

  • Detection of 200+ metabolites per single cell using advanced IMS-resolved nanoESI-MS techniques
  • +1 more outcomes

Companies that use Creative Proteomics

Customer profile

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Creative Proteomics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Creative Proteomics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Creative Proteomics competitors and assessment

Company assessment

Direct peers

  • Metabolon: Specialized metabolomics CRO offering untargeted and targeted metabolite profiling services using mass spectrometry. Directly comparable to Creative Proteomics's metabolomics service line and competes for the same pharma and academic sponsors.
  • Biognosys: Proteomics-focused CRO providing discovery proteomics, targeted proteomics (using its Spectronaut software), and protein biomarker services. Most direct head-to-head competitor for Creative Proteomics's proteomics service line.
  • Novogene: Multi-omics services provider offering genomics, proteomics, and metabolomics on a fee-for-service basis. Directly comparable service model, customer mix, and global intake footprint.

Broad incumbents

  • Eurofins Scientific: Global testing CRO with a sizeable biopharma services division covering proteomics, metabolomics, and genomics. Overlaps broadly with Creative Proteomics but operates at vastly larger scale and with broader geographic reach.
  • Charles River Laboratories: Large CRO offering discovery, safety assessment, and laboratory services including protein characterization and bioanalytical support. A scaled incumbent competing for the same biopharma outsourcing dollars.
  • Thermo Fisher Scientific (PPD): Owns both the dominant mass-spectrometry instrument line (Orbitrap, Q Exactive) used by Creative Proteomics and the PPD CRO business. A vertically integrated incumbent that competes as both vendor and analytical-services provider.
  • WuXi AppTec: Global CRO/CDMO offering discovery, preclinical, and laboratory services to biopharma. Competes on multi-omics and bioanalytical work and operates at much larger scale with broader geographic coverage.
  • Evotec: Drug-discovery CRO offering proteomics, metabolomics, and integrated multi-omics as part of broader discovery collaborations. Overlaps with Creative Proteomics's MassTarget drug-discovery workflow.
  • GenScript: Life-science services company offering gene synthesis, protein production, peptide synthesis, and analytical services. Comparable on the custom peptide/protein synthesis and protein characterization lines, broader in scope elsewhere.

Emerging players

  • Olink Holding: Proteomics platform company offering targeted protein biomarker analysis via Proximity Extension Assay. Adjacent rather than direct, since Olink sells a kit-and-platform model, but it overlaps with Creative Proteomics's targeted proteomics workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Creative Proteomics social profiles

Digital presence

Creative Proteomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Creative Proteomics leadership team

Management profile

Number of profiles

Creative Proteomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Creative Proteomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Proteomics

What does Creative Proteomics do?

Creative Proteomics is a contract research organization that delivers mass spectrometry- and NMR-based analytical services spanning proteomics, metabolomics, lipidomics, glycomics, peptidomics, spatial omics, and bioinformatics. Customers submit biological samples and receive quantitative analytical results with data interpretation, supported by specialized drug discovery offerings via its MassTarget™ platform. The company serves pharmaceutical, biotechnology, and academic research customers globally.

Is Creative Proteomics a public or private company?

Creative Proteomics is a private company. It is classified as unknown and is currently operating.

When was Creative Proteomics founded?

Creative Proteomics was founded in -1. It employs 1 to 10 people.

Where is Creative Proteomics based?

Creative Proteomics is headquartered in Shirley, United States, in the North America region.

How does Creative Proteomics make money?

One revenue line is on record: laboratory Testing Services.

Who are Creative Proteomics's main competitors?

Direct peers on record are Metabolon, Biognosys and Novogene. Broad incumbents are Eurofins Scientific, Charles River Laboratories, Thermo Fisher Scientific (PPD), WuXi AppTec, Evotec and GenScript. Olink Holding is listed as an emerging player.

Does Creative Proteomics have an API?

No public API is recorded for Creative Proteomics.

What industry is Creative Proteomics in?

Creative Proteomics's product category is Analytical Laboratory Services. Its primary akta.pro industry code is HLAGANAB, Proteomics & Mass Spectrometry Services, with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 541714.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Creative-ProteomicsMulti-omics Integrative ServicesThe article presents a collection of client testimonials praising the proteomics and multi-omics integrative services provided by Creative Proteomics. Clients from academic institutions highlight the company's data quality, technical expertise in mass spectrometry, and collaborative support for their research projects. The content serves as promotional material showcasing successful collaborations on studies involving yeast models, cancer biomarkers, gut microbiota, and plant physiology.BioSpaceCreative Proteomics Launches BioID Platform for Proximity-Dependent Biotin IdentificationCreative Proteomics launched its BioID platform for proximity-dependent biotin identification, using a promiscuous biotin ligase to label nearby proteins. The platform enables mass spectrometry-based identification of protein targets in complex cellular environments, supporting applications in drug discovery and biomarker research.openPR.comPeptide Microarray Assay Service Industry Market Report 2022 : Detail Research on Global Growth Size, Insights and Forecast: JPT, LC Sciences, Creative ProteomicsStratagem Market Insights published a market research report forecasting the global Peptide Microarray Assay Service industry from 2022 to 2030. The study analyzes market size, growth drivers, and competitive landscapes for key players including JPT, LC Sciences, and Creative Proteomics. It provides detailed segmentation by product type, application, and region to guide stakeholder investment decisions.